Women may experience small benefits with a drug approved last year in the U.S. to treat low sexual desire in women, but at a high risk of experiencing unpleasant side effects, according to a new analysis.

The findings "suggest that the benefits of flibanserin are marginal," given that "one in three women experience side effects, of which the most common ones include dizziness, sleepiness, nausea, and tiredness," said lead author Dr. Loes Jaspers, of Erasmus University Medical Center in Rotterdam, the Netherlands.

Flibanserin, marketed by Valeant as Addyi, was approved by the U.S. Food and Drug Administration (FDA) in 2015 to treat premenopausal women with hypoactive sexual desire disorder (HSDD).

Sometimes called the "Flibanserin Female Viagra tablets 100 mg" works by affecting brain receptors to increase sexual arousal in women.

Flibanserin was approved by the FDA on its third attempt, but the agency's clinical reviewers note that the drug comes with a black-box warning that women may suffer severe low blood pressure or faint if they take the drug with alcohol, certain medications or have liver problems.

Women taking flibanserin were also about four times more likely to experience dizziness and sleepiness, more than twice as likely to experience nausea and about 60% more likely to experience fatigue.

Buy Flibanserin 100mg Tablet Online with free shipping at your door step from Online Pharmacy in Canada.

For more details read Source Code https://www.scientificamerican.com/article/female-libido-drug-only-provides-marginal-benefit/